TATYY TATE & LYLE SPON ADR EACH REP 4 ORD
- 32.980
- 0.0000.00%
TATE & LYLE SPON ADR EACH REP 4 ORD News
Tate & Lyle Target Started at 850.00p by Deutsche Bank
Tate & Lyle Target Started at 850.00p by Deutsche Bank
Shareholders in Tate & Lyle (LON:TATE) Are in the Red If They Invested Three Years Ago
Tate & Lyle's Revenue Drop Doesn't Hurt Confidence on Profit Target -- Market Talk
0839 GMT - Tate & Lyle's 3Q confirms profit outlook despite lowered revenue expectations due to deflationary pressures in pricing, Citi analysts write. The food-and-beverage ingredients posted a reven
Tate & Lyle Expects Volume Recovery Ahead After Weak Third Quarter
By Elena Vardon Tate & Lyle expects to return to volume growth after softer demand and customer destocking weighed on its third-quarter revenue. The provider of food-and-beverage ingredients on Wedn
Tate & Lyle's Long-Term Prospects Remain Intact -- Market Talk
1042 GMT - Tate & Lyle's headwinds could largely abate by the end of fiscal 2024, while its long-term outlook remains attractive, Berenberg analysts say in a note. The provider of food-and-beverage in
TATE & LYLE SPON ADR EACH REP 4 ORD To Go Ex-Dividend On November 22nd, 2023 With 0.30424 USD Dividend Per Share
November 15th - $TATE & LYLE SPON ADR EACH REP 4 ORD(TATYY.US)$ is trading ex-dividend on November 22nd, 2023. Shareholders of record on November 24th, 2023 will receive 0.30424 USD dividend per s
Tate & Lyle Sees Earnings Growth After Profit Rises
By Michael Susin Tate & Lyle reported a pretax profit increase for the first half of fiscal 2024 on the back of lower costs and robust profits from its minority holding in plant-based ingredient make
Tate & Lyle 1H Oper Pft GBP123M
Tate & Lyle 1H Oper Pft GBP123M
Tate & Lyle Appoints David Hearn Chairman; Interim Chair Warren Tucker to Step Down
By Anthony O. Goriainoff Tate & Lyle said David Hearn has been appointed director and chair of the board from Jan. 1 and will succeed interim Chair Warren Tucker. The FTSE 250 provider of food-and-b
Tate & Lyle's Growth Seen at Risk as Appetite-Loss Drug Spreads in US -- Market Talk
0955 GMT - Tate & Lyle is the most exposed European stock in the U.S. end-market, where new GLP-1 drugs such as which slow digestion and depress appetite--are affecting consumption patterns, Barclays
Tate & Lyle Cut to Equalweight From Overweight by Barclays
Tate & Lyle Cut to Equalweight From Overweight by Barclays
Tate & Lyle Chairman Gerry Murphy to Step Down, Warren Tucker Named Interim
By Anthony O. Goriainoff Tate & Lyle said Monday that Gerry Murphy will step down as chairman to take up the position at Tesco on Sept. 1, with Warren Tucker appointed interim chairman from that date
Tesco Taps Tate & Lyle, Burberry Chairman Gerry Murphy
By Anthony O. Goriainoff Tesco said Saturday that Gerry Murphy has been appointed chairman and will join the board on Sept. 1, and that interim chairman Byron Grote will step down and revert back to
Tate & Lyle Shares Could Get Boost After Upbeat FY Results -- Market Talk
1239 GMT - Tate & Lyle rises 2% after the food-ingredient group reported higher revenue and adjusted earnings in the year to the end of March. The company's second-half adjusted pretax earnings before
Tate & Lyle Pretax Profit Jumped on Food & Beverage Solutions Growth
By Christian Moess Laursen Tate & Lyle said Thursday that its pretax profit more than tripled in fiscal 2023 thanks to a jump in revenue driven by its food and beverages solutions. The FTSE 250 p
Express News | Tate & Lyle FY Adjusted Ebitda GBP320M
Tate & Lyle Targets Revenue Growth of 4% to 6% Over 5 Years
Tate & Lyle Targets Revenue Growth of 4% to 6% Over 5 Years
Tate & Lyle To Deliver Progress in Line With Five-Year Ambition
Tate & Lyle To Deliver Progress in Line With Five-Year Ambition
Express News | Tate & Lyle Targets Adjusted Ebitda Growth of 7% to 9% Over 5 Years
Express News | Tate & Lyle Free Cash Flow GBP119M
Analysis
Price Target
No Data
